A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Schouten, Jeffrey T ^a   Lockhart, David W ^b   Rees, Thomas S ^a   Collier, Ann C ^b   Marra, Christina M ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXPOSURE; FEMALE; HEARING IMPAIRMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; MALE; NOISE; PERCEPTION DEAFNESS; PILOT STUDY; PROSPECTIVE STUDY; PURE TONE AUDIOMETRY;

ADULT; AGING; ANTI-HIV AGENTS; DIDANOSINE; FEMALE; HEARING LOSS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ZIDOVUDINE;

EID: 33646119869     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-28     Document Type: Article

References (12)

1. Marra CM, Wechkin HA, Longstreth WT, Rees T, Syapin CL, Gates GA: Hearing loss and antiretroviral therapy in patients infected with HIV-1. Arch Neurol 1997, 54(4):407-410.
2. Simdon J, Watters D, Bartlett S, Connick E: Ototoxicity associated with use of nucleoside analog Reverse transcriptase inhibitors: A report of 3 possible cases and review of the literature. CID 2001, 32:1623-7.
3. McNaghten AD, Wan PT, Dworkin MS: Correspondence: Prevalence of hearing loss in a cohort of HIV-infected patients. Arch Otolaryngol Head Neck Surg 2001, 127:1516-1518.
4. Lalwani AK, Sooy CD: Otologic and neurotologic manifestations of acquired immunodeficiency virus Infection. Otolaryngol Clin North Am 1992, 25:1183-97.
5. Kakuda TN: Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 2000, 22(6):685-708.
6. Prince MM, Gilbert SJ, Smith RJ, Stayner LT: Evaluation of the risk of noise-induced hearing loss among unscreened male industrial workers. J Acoust Soc Am 2003, 113(2):871-880.
7. Aguilar-Markulis NV, Beckley S, Priore R, Mettlin C: Auditory toxicity effects of long-term cis-dichlorodiamminepaltinum II therapy in genitourinary cancer patients. J Surg Oncol 1981, 16:111-123.
8. Long SJ, Laurie EH: Using heteroscedasticity consistent standard errors in the linear regression model. The American Statistician 2000, 54:217-224.
9. Liang K-Y, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
10. Rey D, L'Heritier A, Lang JM: Correspondence: Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine and nevirapine after occupational exposure to HIV. CID 2002, 34:418-19.
11. Williams B: Correspondence: Ototoxicity may be associated with protease inhibitor therapy. CID 2001, 33:2100-01.
12. Simdon J, Watters D, Bartlett S, Connick E: Reply. CID 2001, 33:2101-02.